Calendar

An AMCP Webinar, hosted by Formulary Decisions® 

Join us for an interactive, engaging, and informative discussion as we dive into the evolving landscape of pre-approval information exchange (PIE). Our diverse panel of biopharma and market access and communication experts will guide you through a live session filled with valuable insights and strategies for engaging healthcare decision-makers with pre-approval information. We will explore opportunities and innovative solutions for leveraging PIE when collaborating with stakeholders.

A Science & Innovation Webinar, presented by Abbvie.

Psoriasis is a chronic, inflammatory, immunologic condition that primarily manifests on the skin, the body’s largest organ. If not properly treated, uncontrolled psoriasis can induce inflammatory processes beyond the skin and may lead to comorbid disease. Comorbidities that may impact psoriasis patients such as psoriatic arthritis (PsA), cardiovascular disease, metabolic syndrome, inflammatory bowel disease (IBD), depression and others add burden to the entire healthcare system and adversely impact patient outcomes.

A Science & Innovation Webinar, presented by Apellis.

Complement 3 Glomerulopathy (C3G) and Primary Immune Complex-mediated Membranoproliferative Glomerulonephritis (IC-MPGN) are two rare, chronic glomerular diseases caused by overactivation of the complement system resulting in severe kidney damage. Webinar topics will include the prevalence, characteristics, and unmet medical needs of patients living with these diseases.
 

A Pre-Approval Information Exchange (PIE) Webinar sponsored by UroGen Pharma, Inc.

This webinar will be hosted by UroGen Pharma, Inc. and will discuss the disease state, product profile, commercialization plans, and clinical information for UGN-102. An investigational drug in development for the treatment of low-grade intermediate risk non-muscle invasive bladder cancer (LG-IR-NMIBC) in adult patients. The safety and efficacy of UGN-102 have not been established by the FDA. This presentation is intended for payors, formulary committees, and similar entities only.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.